2024-09-07 - Analysis Report
## JNJ Stock Analysis Report

**Company:** Johnson & Johnson (JNJ) is a multinational pharmaceutical, medical device, and consumer packaged goods company.

**Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** JNJ: 20.84%, VOO: 84.86%
* **Performance Gap:** -69.78% (relative divergence of 12.84%) 
* **Interpretation:** JNJ has significantly underperformed the S&P 500 over the period considered. While it's important to note that this doesn't guarantee future performance, it suggests that JNJ has faced challenges compared to the broader market.

**Recent Price Movement:**

* **Closing Price:** $167.36
* **5-Day Moving Average:** $165.71
* **20-Day Moving Average:** $161.94
* **60-Day Moving Average:** $154.86
* **Interpretation:**  The recent price action suggests a short-term upward trend. The closing price is above all moving averages, indicating potential buying pressure.

**Technical Indicators:**

* **RSI:** 86.39 - Indicates overbought conditions, suggesting potential for a near-term correction.
* **PPO:** 0.18 -  Suggests bullish momentum.
* **Delta_Previous_Relative_Divergence:** -9.44  -  Indicates short-term downward divergence.
* **Expected Return:** 11.93% - Represents the estimated potential return for a 5-year investment.

**Recent Earnings:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | $22.45 B |
| 2024-05-01 | 1.35 | $21.38 B |
| 2024-02-16 | 1.68 | $21.39 B |
| 2023-10-27 | 10.32 | $21.35 B |
| 2024-02-16 | 10.32 | $21.35 B | 

**Analysis:** 
* Recent earnings have been mixed, with some quarters exceeding expectations and others falling short. 
* The company has experienced revenue growth in the past few quarters.
* It's important to consider future earnings estimates to evaluate potential growth and investment opportunities.

**Overall Analysis:**

JNJ exhibits a complex picture. Despite underperforming the market significantly, the stock shows signs of recent strength, with bullish momentum and positive short-term price action. However, overbought conditions and a short-term downward divergence in the relative divergence suggest potential for a near-term correction. The recent earnings picture offers mixed signals, requiring further analysis of future earnings estimates to assess its long-term growth prospects. It's important to consider the company's long-term strategy and future growth plans, especially in the context of its diverse business lines, when making investment decisions. 
